| P50 | author | Nicolas A Giraldo | Q56839639 |
| | Marie-Caroline Dieu-Nosjean | Q37277793 |
| | Catherine Sautès-Fridman | Q40020459 |
| | Wolf Hervé Fridman | Q40876588 |
| P2093 | author name string | Claire Germain | |
| | Hélène Kaplon | |
| P2860 | cites work | Involvement of chemokine receptors in breast cancer metastasis | Q24290909 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules | Q24685626 |
| | Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. | Q27310763 |
| | Cancer-related inflammation | Q27860907 |
| | From mice to humans: developments in cancer immunoediting | Q28088304 |
| | Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 |
| | Interleukin-21 inhibits dendritic cell activation and maturation | Q28191392 |
| | Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab | Q28265584 |
| | A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment | Q28285117 |
| | Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes | Q28384201 |
| | Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation | Q28585797 |
| | ICOS is essential for effective T-helper-cell responses | Q28594859 |
| | Cancer immunotherapy via dendritic cells | Q29615444 |
| | Cancer immunotherapy comes of age | Q29619918 |
| | The immune contexture in human tumours: impact on clinical outcome | Q29620667 |
| | Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules | Q30047232 |
| | Immune responses elicited in tertiary lymphoid tissues display distinctive features | Q33627619 |
| | IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism | Q33656121 |
| | B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer | Q33721433 |
| | CCL21 Cancer Immunotherapy | Q33820300 |
| | Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation | Q33848077 |
| | Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions | Q33862762 |
| | The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes | Q33877237 |
| | Effector memory T cells, early metastasis, and survival in colorectal cancer | Q33992461 |
| | Crucial roles of interleukin-7 in the development of T follicular helper cells and in the induction of humoral immunity | Q34059261 |
| | Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response | Q34078561 |
| | Interleukin-21 promotes germinal center reaction by skewing the follicular regulatory T cell to follicular helper T cell balance in autoimmune BXD2 mice | Q34098180 |
| | Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma | Q34105741 |
| | Manifestation of spontaneous and early autoimmune gastritis in CCR7-deficient mice | Q42128925 |
| | The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients | Q44009560 |
| | Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells | Q44200118 |
| | IL-7 modulates in vitro and in vivo human memory T regulatory cell functions through the CD39/ATP axis. | Q44406687 |
| | T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6. | Q44908649 |
| | Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity | Q45018410 |
| | Characteristics and significance of colorectal cancer associated lymphoid reaction | Q45027953 |
| | Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers | Q45118047 |
| | High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma | Q45875161 |
| | The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer. | Q46064083 |
| | Inhibition of generation of cytotoxic T lymphocyte activity by a CCL19/macrophage inflammatory protein (MIP)-3beta antagonist | Q47253731 |
| | The association of CXCR3 and renal cell carcinoma metastasis. | Q50722974 |
| | Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma. | Q50909597 |
| | IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells. | Q50929763 |
| | ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells. | Q50935651 |
| | Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. | Q50993488 |
| | Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. | Q50996147 |
| | Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. | Q51798642 |
| | Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. | Q51889629 |
| | Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. | Q51985115 |
| | Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. | Q52022097 |
| | The IL-7 signaling pathway regulates lymph node development independent of peripheral lymphocytes. | Q52599046 |
| | Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. | Q52656274 |
| | Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma. | Q54577719 |
| | Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Q54618275 |
| | Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. | Q54690889 |
| | Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer | Q56965679 |
| | Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin | Q56965716 |
| | Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures | Q56965922 |
| | Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice | Q34110300 |
| | A cytokine-delivering polymer is effective in reducing tumor burden in a head and neck squamous cell carcinoma murine model | Q34205801 |
| | Interleukin-7 influences FOXP3+CD4+ regulatory T cells peripheral homeostasis | Q34269144 |
| | Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma | Q34499441 |
| | Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy | Q34571305 |
| | Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses | Q34591141 |
| | Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis | Q34657157 |
| | A fundamental role for interleukin-21 in the generation of T follicular helper cells | Q34792475 |
| | Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. | Q35013206 |
| | Meta-analysis identifies NF-κB as a therapeutic target in renal cancer | Q35014835 |
| | RANK-Fc: a therapeutic antagonist for RANK-L in myeloma | Q35053943 |
| | Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling | Q35070183 |
| | Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations. | Q35070193 |
| | CXCL13 antibody for the treatment of autoimmune disorders | Q35086918 |
| | Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression | Q35499771 |
| | Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma | Q35527136 |
| | Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer | Q35587652 |
| | IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses | Q35601173 |
| | Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis | Q35764191 |
| | Local expression of secondary lymphoid tissue chemokine delivered by adeno-associated virus within the tumor bed stimulates strong anti-liver tumor immunity | Q35947942 |
| | Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza | Q35973395 |
| | Anti-IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function | Q36140610 |
| | Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine | Q36190058 |
| | In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor | Q36229738 |
| | A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4(+) T cell receptor repertoire clonality | Q36256308 |
| | Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer | Q36285953 |
| | High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes | Q36373347 |
| | Distinctive features of the differentiated phenotype and infiltration of tumor-reactive lymphocytes in clear cell renal cell carcinoma | Q36442539 |
| | Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature | Q36614453 |
| | Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients | Q36710911 |
| | Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells | Q36839509 |
| | CD4⁺ follicular helper T cell infiltration predicts breast cancer survival | Q36966923 |
| | Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response | Q37397090 |
| | Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma | Q37427684 |
| | Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). | Q37684283 |
| | RANK/RANKL/OPG role in distraction osteogenesis | Q37694061 |
| | Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. | Q37700808 |
| | The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development | Q37770209 |
| | New insights into the development of lymphoid tissues | Q37779724 |
| | Tumor microenvironment is multifaceted | Q37832693 |
| | Targeting costimulatory molecules to improve antitumor immunity. | Q38002404 |
| | HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes | Q38047190 |
| | Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease | Q38091729 |
| | The immune contexture of primary and metastatic human tumours | Q38184320 |
| | Leukocyte migration in the interstitial space of non-lymphoid organs. | Q38193988 |
| | Ectopic lymphoid-like structures in infection, cancer and autoimmunity | Q38221815 |
| | Tertiary lymphoid structures in cancer and beyond | Q38274486 |
| | The role of IL-21 in immunity and cancer | Q38313190 |
| | Osteoblast-secreted factors enhance the expression of dysadherin and CCL2-dependent migration of renal carcinoma cells. | Q38337275 |
| | The immune response in cancer: from immunology to pathology to immunotherapy | Q38528448 |
| | Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity | Q38926338 |
| | The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells | Q38980079 |
| | Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibition | Q39085608 |
| | A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection | Q39470034 |
| | Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells | Q39628656 |
| | Rational design of interleukin-21 antagonist through selective elimination of the gammaC binding epitope | Q39737725 |
| | Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. | Q40215535 |
| | IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses. | Q40261030 |
| | Human renal cell carcinoma inhibits dendritic cell maturation and functions | Q40554162 |
| | Dangers of using "optimal" cutpoints in the evaluation of prognostic factors | Q40752297 |
| | Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison. | Q41218764 |
| | Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer | Q41422453 |
| | Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting | Q41590541 |
| | Regulation of tumor-associated high-endothelial venules by dendritic cells: A new opportunity to promote lymphocyte infiltration into breast cancer? | Q41882516 |
| | 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? | Q41883987 |
| | Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice | Q42036256 |
| P433 | issue | 1 | |
| P921 | main subject | tertiary lymphoid structure | Q54928327 |
| P304 | page(s) | 260-275 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Immunological Reviews | Q15724582 |
| P1476 | title | Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers | |
| P478 | volume | 271 | |